Brevetti EPO No.3823617 2024.03.06
Brevetti EPO
(10) Registration Number and Date
2024000205 2024.06.25
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2024/000205 2019.07.22
(40) Publication Number and Date
SM /T/2024/000205 2024.06.25
(30) Priority Details
US 201862701726 P
2018.07.21
(51) IPC Classes
(71/73) Applicant
(IT) LINNAEUS THERAPEUTICS, INC. : 30 Washington Ave Suite F, Haddonfield NJ 08033, US
(72) Inventor
(IT) NATALE, Christopher : 717 S 19th Street, Apt. 2, Philadelphia, Pennsylvania 19146, US
(IT) GARYANTES, Tina : 18 Roberts Rd., Warren, New Jersey 07059, US
(IT) MOONEY, Patrick : 625 Clinton Ave., Haddonfield, New Jersey 08033, US
(74) Representative Name
(IT) BUSCA, Andrea : Strada Caiese, 30, 47891 Dogana RSM, SM
(54) Title
(IT) AGONISTA DI GPER ENANTIOMERICAMENTE PURIFICATO PER USO NEL TRATTAMENTO DI STATI E CONDIZIONI DI MALATTIA
(EN) ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2024.07.10
Event NameDateStatus
Filing2019.07.22Filed
Ricevuta pagamento annualita 62024.06.25Payed